| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 277,092 | 270,129 | 295,741 | 305,239 | | Cost of Revenue | 214,574 | 208,815 | 246,348 | 251,030 | | | Gross Profit | 62,518 | 61,314 | 49,393 | 54,209 | | | Operating Expenses | | Research Development | 31,440 | 30,734 | 18,971 | 21,324 | | Selling General and Administrative | 17,496 | 17,759 | 19,258 | 16,081 | | Non Recurring | (1,300) | 1,300 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 14,882 | 11,521 | 11,164 | 16,804 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,723) | 2,450 | 4,963 | (4,819) | | Earnings Before Interest And Taxes | 12,159 | 13,971 | 16,127 | 11,985 | | Interest Expense | 2,327 | 2,157 | 2,257 | 1,083 | | Income Before Tax | 9,832 | 11,814 | 13,870 | 10,902 | | Income Tax Expense | 450 | 3,075 | 4,668 | 1,210 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 9,382 | 8,739 | 9,202 | 9,692 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 9,382 | 8,739 | 9,202 | 9,692 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $9,382 | $8,739 | $9,202 | $9,692 |
|
0.07% Nasdaq 
Income Statement
